Investor Information

Prana Biotechnology is developing best-in-class therapies to treat neurodegenerative disease.  

The Company was incorporated in 1997 in Melbourne, Australia and listed on the Australian Securities Exchange in 2000 (ASX: PBT) and NASDAQ in 2002 (NASDAQ: PRAN).

Governance Documents

ASX Announcements

Financial Reports

Archived Reports